Clinical Trials Directory

Sugars in Cigarettes

A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)

Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer

Dutch Multidomain Lifestyle Intervention in Older Adults at Risk of Cognitive Decline

A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling

Amyloidosis TTR Flow Reserve Evaluation

Decreasing Antibiotic Prescribing in Acute Respiratory Infections Through Nurse Driven Clinical Decision Support

IDEntification of New Predisposition Genes in Differentiated THYroid Cancer

Evaluating the Impact of Computer-assisted X-ray Diagnosis and Other Triage Tools to Optimise Xpert Orientated Community-based Active Case Finding for TB and COVID-19

Atropine and Spectacle Combination Treatment (ASPECT): 12-month Results of a Randomized Clinical Trial for Myopia Control

Ruxolitinib for Cancer Cachexia

Corneal Flap Transplantation for Macular Hole Repair of High Myopia

Bioneer IRONqPCR ™ RFIA Kit Kit Clinical Evaluation

Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer

A Two Year Longitudinal Clinical Study of Neurocognitive and Psychiatric Symptoms in Post COVID-19 Patients

Study of a Pembrolizumab-based Organ Preservation Strategy for Locally Advanced Larynx Cancers

Monopolar and Bipolar Current RFA Knife in POEM

Physical Activity and Disability Prevention in Postmenopausal Women

Setrusumab vs Placebo for Osteogenesis Imperfecta

Evaluating Prenatal Exome Sequencing Study

A Global Study to Assess the Effects of Osimertinib in Participants With EGFRm Stage IA2-IA3 NSCLC Following Complete Tumour Resection

Peri-implant Tissues on the Galimplant Anti-rotational Slim Abutment.

Optimization and Multi-Site Feasibility of Yoga for Chronic Pain in People in YOGAMAT-II - Phase II

Long Term Effect of Very-low-calories Ketogenic Diet on Weight Control and Cardiovascular Brisk Factors (KETOHEART)

Metacognitive Training With Bipolar Disorder Patients.

MSC in Patients With Xerostomia Post XRT in Head and Neck Cancer

Obinutuzumab in Primary MN

Erythropoietin Therapy to Induce Regulatory T Cells in Liver Transplant Recipients

Efficacy, Immunogenicity, and Safety of V503 in Chinese Males (V503-052)

fMRI in Postural Tachycardia Syndrome

Follow-up of Immunological Pattern and Pregnancy Outcomes in Women Previously Received Placental Malaria Vaccine

Clinical Outcome and Fusion Rate of 3D Printed Interbody Fusion Cages and Titanium Coated PEEK Cages

A Study of Real Life Treatment for Multiple Myeloma (MM)

Phase I Study of TSN084 in Patients With Advanced Malignant Tumors.

Clinical Impact of the IBox As an Early Intervention TooL

Birth Control to Improve Birth Spacing

Acetazolamide Trial in Normal Pressure Hydrocephalus

RCT on Nonoperative Versus Operative Treatment for Acute Complete tearS of the Ulnar Collateral ligAment of the Thumb

Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung Cancer

Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer

JAB-21822 in Combination With Cetuximab in Patients With Advanced CRC and Other Solid Tumors With KRAS G12C Mutation

D,L-MEthadone and mFOLFOX6 in Treatment of Advanced Colorectal Cancer

Developing a Shared Decision Making Tool for Patients With Surgically Removed Non-small Cell Lung Cancer

A Phase Ib/II Study of the Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabG

Keep Contraceptive Arm Long Acting-iMplant (CALM) and Carry On

Antibacterial Mouthwash for Pharyngeal Gonorrhea Prevention

A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration

A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer

Culturally Smart Relationships Study

Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer